The UK government has announced a £25 million boost for hospices across England, marking the first phase of a larger £100 million investment to improve the quality of end-of-life care.
Santosh Rao, Channing J. Paller, Ana Maria Lopez, Eugene Ahn, Jodi MacLeod, Ting Bao, and Linda E. Carlson, from the Society for Integrative Oncology, detail how integrative oncology is transforming cancer care.
Digital transformation offers many organisations the opportunity to reduce costs, offer superior service and certainly, in Healthcare, improve outcomes. Paul Grosvenor, MD at Optima Systems, an information technology company based in West Sussex, recounts his experiences to date.
Geoff Twist, Managing Director of Roche Diagnostics UK & Ireland, says that the UK's inability to get diagnostic innovation to the frontline is hampering the NHS and the nation's health; this is a missed opportunity.
Dr Natasha Azzopardi Muscat, Dr Tomas Zapata and Dr Satish Mishra, from WHO/Europe, argue that now is time to strengthen palliative care across the European Region.
Recent figures show that the number of people in England NHS waiting lists has jumped to a record 6.8 million - but could this decrease with volunteers?
David Bloomfield, Consultant in Clinical Oncology Sussex Cancer Centre, argues that precision radiotherapy is our most effective cancer treatment and should be available to everyone with cancer, but workforce planning is failing our patients.
The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.
Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Rob Banathy, Senior Product Manager at NHS Digital, explains how his team developed a lateral flow device digital reader service that can detect nearly twice the number of positive COVID-19 cases during early infection compared to the human eye.
